Codexis Inc
CDXS
$1.36+0.00%
Delayed · as of Oct 7, 2026, 10:16 AM ET
Mkt cap
$257.65M
EV/Sales
3.51
P/E ratio
N/A
FY2025 Revenue
$70.39M
EPS (TTM)
$-0.33
Gross Margin (FY2025)
86.73%
Profit Margin (FY2025)
-62.47%
Beta
2.53
Div yield
N/A
Sector
Healthcare
Codexis Inc (CDXS) is a biotechnology company listed on US.
Latest reported CDXS revenue for 2025-12-31 was $70.4M. Net income was -$44.0M. Revenue was up 18.6% from 2024-12-31 to 2025-12-31. CDXS currently screens at market cap $257.6M.
Use this CDXS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CDXS income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Codexis Inc (CDXS) is a biotechnology company in the Healthcare sector.
Latest cached Codexis Inc (CDXS) revenue for Dec 31, 2025 was $70.4M. Net income was -$44.0M. Statements: https://lician.com/financials/cdxs
Codexis Inc (CDXS) market capitalization is $257.6M on the latest cached snapshot.
Codexis Inc (CDXS) cached previous close $1.36; day range $1.33 – $1.36; volume 42,808. Session quote: https://lician.com/quote/cdxs
Codexis Inc (CDXS) latest cached earnings event is "CDXS earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CDXS filing is 8-K · Jun 22, 2026. Filings: https://lician.com/sec/cdxs